Melatonin participates in organism protection against infection



Cite item

Full Text

Abstract

In this review, the recent experimental and clinical data about protective effects of melatonin produced by pineal gland and peripheral cells, against different kind of infections are observed. The cellular and systemic mechanisms of its protective activity and therapeutic possibilities are also discussed.

About the authors

Eduard Beniaminovich Arushanyan

Stavropol State Medical Academy

Email: eduard.arush@mail.ru
Dr. Med. Sci. (Pharmacology), Professor, Head, Dept. of Pharmacology

References

  1. Анисимов В. Н. Мелатонин: роль в организме, применение в клинике. - СПб: Система, 2007, 40 с.
  2. Арушанян Э. Б. Уникальный мелатонин. - Ставрополь, 2006. 399 с.
  3. Арушанян Э. Б. Защитная роль мелатонина при нарушениях мозгового кровообращения // Рус. мед. журн. - 2010. - Т. 18, № 6 - С. 57-61.
  4. Арушанян Э. Б. Эпифизарный гормон мелатонин в комбинированной фармакотерапии заболеваний головного мозга и внутренних органов // Экспер. и клин. фармакол. - 2011. - Т. 74, № 9. - С. 39-45.
  5. Арушанян Э. Б. Мелатонин - универсальный стабилизатор психической деятельности // Журн. высш. нервн. деят. - 2011. - Т. 61, № 6. - С. 645-659.
  6. Арушанян Э. Б. Ограничение окислительного стресса как основная причина универсальных защитных свойств мелатонина // Экспер. и клин. фармакол. - 2012. - Т. 75, № 5. - С. 44-49.
  7. Арушанян Э. Б., Бейер Э. В. Иммунотропные свойства эпифизарного мелатонина // Экспер. и клин. фармакол. - 2002. - Т. 65, № 5. - С. 73-80.
  8. Джериева И. С., Волкова Н. И. Нитрооксидативный стресс и возможности его коррекции мелатонином // Мелатонин: перспективы применения в клинике. - М.: Имапресс, 2012. - С. 125-134.
  9. Кветной И. М., Кветная Т. В., Райхлин Н. Т. Экстрапинеальный мелатонин: место и роль в нейроэндокринной регуляции гомеостаза // Мелатонин в норме и патологии. - М.: Медпрактика, 2004. - С. 34-47.
  10. Малиновская Н. К., Рапопорт С. И. Роль мелатонина в регуляции функций желудочно-кишечного тракта // Мелатонин в норме и патологии. - М.: Медпрактика, 2004. - С. 102-113.
  11. Akcan A., Kucuk C., Sozuer E. et al. Melatonin reduces bacterial translocation and apoptosis in experimental colitis of rats // World J. Gastroenterol. - 2008. - Vol.14. - P. 918-924.
  12. Bagci S., Horoz O., Yidizdas D. et al. Melatonin status in pediatric intensive care patients with sepsis // Pediatr. Crit. Care Med. - 2012. - Vol. 13. - P. e120-e123.
  13. Brazao V., Del Vecchio Filip M., Santello F. H. et al. Melatonin and zinc treatment: distinctive modulation of cytokine production in chronic experimental Trypanosoma cruzi infection // Cytokine - 2011. - Vol. 56. - P. 627-632.
  14. Bubenik G. A. Thirty four years since the discovery of gastrointestinal melatonin // J. Physiol. Pharmacol. - 2008. - Vol. 59, Suppl.2 - P. 33-51.
  15. Cardinali D. P., Alvarez C. B. Melatonin in Chagas’ disease. Possible therapeutic value // Medicine (B. Aires) - 2011. - Vol. 71. - P. 471-483.
  16. Carrillo-Vico A., Reiter R. J., Lardone P. J. et al. The modulatory role of melatonin on immune responsiveness // Curr. Opin. Investig. Drugs - 2006. - Vol. 7. - P.423-431.
  17. Celinski K., Konturek P. C., Konturek S. J. et al. Effect of melatonin and tryptophan on healing of gastric duodenal ulcers with Helicobacter pylori infection in humans // J. Physiol. Pharmacol. - 2011. - Vol. 62. - P. 521-526.
  18. De la Rocha N., Rottelli A., Aguilar C. F. Structural basis of the anti-inflammatory activity of melatonin // Arzneimittelforschung - 2007. - Vol. 57. - P. 782-786.
  19. Espino J., Bejarano I., Parades S. et al. Protective effect of melatonin against human leukocyte apoptosis induced by intracellular calcium overload: relation with its antioxidant actions // J. kPineal Res. - 2011. - Vol. 51. - P. 195-206.
  20. Esposito E., Paterniti I., Mazzon E. et al. Melatonin reduces hyperalgesia associated with inflammation // J. Pineal Res. - 2010. - Vol. 49. - P. 321-331.
  21. Gitto E., Karbownik M., Reiter R. J. et al. Effect of melatonin treatment in septic newborns // Pediatr. Res. - 2001. - Vol. 50. - P. 756-760.
  22. Gitto E., Pellegrino S., Gitto P. et al. Oxidative stress of the newborn in the pre- and postnatal period and the clinical utility of melatonin // J. Pineal Res. - 2009. - Vol. 46. - P. 128-131.
  23. Grassi-Zucconi G., Sempreviro M., Mocaer E. et al. Melatonin and its new agonist S-20098 restore synchronized sleep fragmented by experimental infection in the rat // Brain Res. Bull. - 1996. - Vol. 39. - P. 63-68.
  24. Hardeland R., Cardinali D. P., Srinivasan V. et al. Melatonin - a pleotropic, orchestrating regular molecule // Progr. Neurobiol. - 2011. - Vol. 93. - P. 350-384.
  25. Huang S. H., Cao X. L., Liu W. et al. Inhibitory effect of melatonin on lung oxidative stress induced by respiratory syncytial virus infection in mice // J. Pineal Res. - 2010. - Vol. 48. - P. 109-116.
  26. Huang S. H., Cao X. L., Wei W. Melatonin decreases TLR3-mediated inflammatory factor expression via inhibition of NF-kappa B activation in respiratory syncytial virus-infected RAW264.7 macrophages // J. Pineal Res. - 2008. - Vol. 45. - P. 98-100.
  27. Imamoglu M., Cay A., Cobanoglu K. et al. Effects of melatonin on suppression of renal scarring in experimental model of pyelonephritis // Urology - 2006. - Vol. 67 - P. 1315-1319.
  28. Klupinska G., Chojnacki C., Harasiuk A. et al. Nocturnal secretion of melatonin in subjects with asymptomatic and symptomatic Helicobacter pylori infection // Pol. Mercur. Lekarski - 2006. - Vol. 21. - P. 239-242.
  29. Kristensson K., Claustrat B., Mhiangra J. D. African trypanosomiasis in the rat alters melatonin secretion and melatonin receptor binding in the suprachiasmatic nucleus // Brain Res. Bull. - 1998. - Vol. 47. - P. 265-269.
  30. Kuehn C. C., Rodrigues Oliveira L., Santos C. et al. Melatonin and dehydroepiandrosterone combination: does this treatment exert a synergistic effect during experimental Trypanocoma cruzi infection? // J. Pineal Res. - 2009. - Vol. 47. - P. 253-259.
  31. Laliena A., San Miguel B., Cresi Z. et al. Melatonin attenuates inflammation and promotes regeneration in rabbits with fulminant hepatitis of viral origin // J. Pineal Res. - 2012. - Vol. 53. - P. 270-278.
  32. Livilti G., Musumeci T., Pignatello R. et al. Antioxidant potential of different melatonin-loaded nanomedicines in an experimental model of sepsis // Exp. Biol. Med. - 2012. - Vol. 237. - P. 670-677.
  33. Longatti P., Perin A., Comai S. et al. A study of tryptophan metabolism via serotonin in ventricular cerebrospinal fluid in HIV-1 infection using a neuroendoscopic technique // Curr. HIV Res. - 2007. - Vol. 5. - P. 267-272.
  34. Lowes D. A., Almawash A. M., Webster N. R. et al. Melatonin and structurally similar compounds have different effects on inflammation and mitochondrial function in endothelial cells under conditions mimicking sepsis // Br. J. Anaesth. - 2011. - Vol. 107. - P. 193-201.
  35. Mаestroni G. J. Melatonin as a therapeutic agent in experimental endotoxic shock // J. Pineal Res. - 1996. - Vol. 20. - P. 84-89.
  36. Miller S. L., Wallace E. M., Walker D. W. Antioxidant therapies: a potential role in perinatal medicine // Neuroendocrinology - 2012. - Vol. 96. - P. 13-23.
  37. Nunnari G., Nigro L., Polermo F. et al. Reduction of serum melatonin levels in HIV-1-infected individuals’ parallel disease progression: correlation with serum interleukin-12 levels // Infection - 2003. - Vol. 31. - P.379-382.
  38. Oda P. S., Rde P. Depression of herpes viral infection symptoms using melatonin and SB-73: comparison with Acyclovir // J. Pineal Res. - 2008. Vol. 44. - P. 373-375.
  39. Oliveira L. G., Kuehn C. C., Santos C. D. et al. Enhanced protection by melatonin and meloxicam combination in experimental infection by Trypanosoma cruzi // Parasite Immunol. - 2010. - Vol. 32. - P. 245-251.
  40. Ozademir D., Uysal N., Turgyan K. et al. The effect of melatonin on endotoxemia-induced intestinal apoptosis and oxidative stress in infant rats // Intensive Care Med. - 2007. - Vol. 33. - P. 511-516.
  41. Ozen I., Ekingen G., Taslipinar M. et al. Effect of melatonin on healing of colonic anastomosis in a rat model of peritonitis // Eur. Surg. Res. - 2007. - Vol. 39. - P. 122-127.
  42. Ozkan E., Yaman H., Cakir E. et al. Plasma melatonin and urinary 6-hydroxymelatonin levels in patients with pulmonary tuberculosis // Inflammation - 2012. - Vol. 35. - P. 1429-1434.
  43. Perras B., Kurowski V., Dodt C. Nocturnal melatonin concentrations is correlated with illness severity in patients with septic disease // Intensive Care Med. - 2006. - Vol. 32. - 625-626.
  44. Reiter R. J., Tan D. X., Parades S. D. Beneficial effects of melatonin in cardiovascular disease // Ann. Med. - 2010. - Vol. 42. - P. 276-285.
  45. Sahib A. S., Al-Jawad F. H., Alkaisy A. A. Effect of antioxidants on the incident of wound infection in burn patients // Ann. Burns Fire Disasters - 2010. - Vol. 23. - P. 199-205.
  46. Sanchez-Barcelo E. J., Mediavilla M. D., Tan D. X. Clinical uses of melatonin: evaluation of human trials // Curr. Med. Chem. - 2010. - Vol. 17. - P. 2070-2095.
  47. Santello F. H., Frare E. O., Caetano L. et al. Melatonin enhances pro-inflammatory cytokines level and protects against Chagas’ disease // J. Pineal Res. - 2008. - Vol. 45. - P. 79-85.
  48. Shang Y., Xu S. P., Wu Y. et al. Melatonin reduces acute lung injury in endotoxemic rats // Chin. Med. J. - 2009. - Vol. 122. - P.1388-1393.
  49. Speer A., Gerber J., Baake D. et al. Antiinflammatory but no neuroprotective effects of melatonin under clinical treatment conditions in rabbit models of bacterial meningitis // J. Neurosci. Res. - 2006. - Vol. 89. - Vol. - P. 1575-1579.
  50. Srinivasan V., Pandi-Perumal S., Spence D. W. et al. Melatonin in septic shock: some recent concepts // J. Crit. Care - 2010. - Vol. 25. - P. 656-660.
  51. Tekbas O. F., Oqur R., Korkmaz A. et al. Melatonin as an antibiotic: new insights into the actions of the ubiquitous molecule // J. Pineal Res. - 2008. - Vol. 44. - P. 222-226.
  52. Tunnon M. J., San Miguel B., Crespo J. et al. Melatonin attenuates apoptotic liver damage in fulminant hepatic failure induced by the rabbit hemorrhagic disease virus // J. Pineal Res. - 2011. - Vol. 50. - P. 38-45.
  53. Valero N., Espino M., Mosquera J. Melatonin decreases nitric oxide production, inducible nitric oxide synthase expression and lipid peroxidation induced by Venezuelan encephalitis equine virus in neuroblastoma cell cultures // Neurochem. Res. - 2006. - Vol. 31. - P. 925-932.
  54. Valero N., Nery A., Bonilla E. Antagonistic effect of luzindole in mice treated with melatonin during the infection with the Venezuelan equine encephalomyelitis virus // Nerochem. Res. - 2009. - Vol. 34. - P. 268-273.
  55. Yever M. B., Yapislar H., Aydogan S. et al. Lipid peroxidation and deformability of red blood cells in experimental sepsis in rats: the protective effects of melatonin // Clin. Hemorheol. Microcirc. - 2004. - Vol. 30. - P. 77-82.
  56. Zhang Z., Araghi-Niknam M., Liang B. et al. Prevention of immune dysfunction and vitamin E loss by dehydroepiandrosterone and melatonin supplemention during murine retrovirus infection // Immunology - 1999. - Vol. 96. - P. 291-297.

Copyright (c) 2014 Arushanyan E.B.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 65565 от 04.05.2016 г.


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies